The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ichiyoshi, Y.
Right arrow Articles by Casali, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ichiyoshi, Y.
Right arrow Articles by Casali, P.

The Journal of Immunology, Vol 154, Issue 1 226-238, Copyright © 1995 by American Association of Immunologists


ARTICLES

A human anti-insulin IgG autoantibody apparently arises through clonal selection from an insulin-specific "germ-line" natural antibody template. Analysis by V gene segment reassortment and site-directed mutagenesis

Y Ichiyoshi, M Zhou and P Casali
Department of Pathology, Cornell University Medical College, New York, NY 10021.

We analyzed the structural correlates underlying the insulin-dependent selection of the specific anti-insulin IgG1 kappa mAb13-producing cell clone, derived from a patient with insulin-dependent diabetes mellitus treated with recombinant human insulin. First, we cloned the germ-line genes that putatively gave rise to the expressed VH and V kappa segments and used them to generate the full (unmutated) "germ-line revertant" of the "wild-type" (somatically mutated) mAb13, using recombinant PCR methods and an in vitro human C gamma 1 and C kappa expression system. The full "germ-line revertant" bound insulin specifically and in a dose-saturable fashion, but with a relative avidity (AVrel) more than three-fold lower than that of its wild-type counterpart (Avrel, 1.69 x 10(-8) vs 4.91 x 10(-9) g/microliters). Second, we established, by reassorting wild-type and germ-line revertant forms of the mAb13 VH and V kappa segments, that the increased Avrel for insulin of mAb13 when compared with its full "germ- line revertant" counterpart was entirely dependent on the mutations in the VH not those in the V kappa chain. Third, we determined, by site- directed mutagenesis experiments, that of the three mutations in the mAb13 VH segment (Ser-->Gly, Ser-->Thr, and Ser-->Arg at positions 31, 56, and 58, respectively), only Arg58 was crucial in increasing the mAb13 Avrel (from 1.44 x 10(-8) to 5.14 x 10(-9) g/microliters) and affinity (Kd, from 189 to 59 nM) for insulin. The affinity enhancement mediated by the VH segment Arg58 residue reflected about a threefold decrease in dissociation rate constant (Koff, from 4.92 x 10(-3) to 1.54 x 10(-3) s-1) but not an increase in association rate constant (Kon, from 2.60 x 10(4) to 2.61 x 10(4) M-1 s-1), and it contrasted with the complete loss of insulin binding resulting from the substitution of the VH segment Asn52 by Lys. The present findings suggest that human insulin, a self Ag, has the potential to recruit a natural autoantibody-producing cell precursor expressing a specific surface receptor for Ag in unmutated configuration, and drive it through affinity maturation. They also show that binding of insulin by such a receptor can be enhanced or completely abrogated by a single amino acid change.


This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Watanabe, S. Miyazawa, M. Kitami, H. Tabunoki, K. Ueda, and R. Sato
Characterization of a Novel C-Type Lectin, Bombyx mori Multibinding Protein, from the B. mori Hemolymph: Mechanism of Wide-Range Microorganism Recognition and Role in Immunity
J. Immunol., October 1, 2006; 177(7): 4594 - 4604.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. F. Widhopf II, D. C. Brinson, T. J. Kipps, and H. Tighe
Transgenic Expression of a Human Polyreactive Ig Expressed in Chronic Lymphocytic Leukemia Generates Memory-Type B Cells That Respond to Nonspecific Immune Activation
J. Immunol., February 15, 2004; 172(4): 2092 - 2099.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M.-J. Jacobin, J. Laroche-Traineau, M. Little, A. Keller, K. Peter, M. Welschof, A. Nurden, and G. Clofent-Sanchez
Human IgG Monoclonal Anti-{alpha}IIb{beta}3-Binding Fragments Derived from Immunized Donors Using Phage Display
J. Immunol., February 15, 2002; 168(4): 2035 - 2045.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Rojas, C. Hulbert, and J. W. Thomas
Anergy and not Clonal Ignorance Determines the Fate of B Cells that Recognize a Physiological Autoantigen
J. Immunol., March 1, 2001; 166(5): 3194 - 3200.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. S. Jethwa, S. H. Clarke, Y. Itoh-Lindstrom, R. J. Falk, J. C. Jennette, and P. H. Nachman
Restriction in V{kappa} Gene Use and Antigen Selection in Anti-Myeloperoxidase Response in Mice
J. Immunol., October 1, 2000; 165(7): 3890 - 3897.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Zan, A. Cerutti, P. Dramitinos, A. Schaffer, Z. Li, and P. Casali
Induction of Ig Somatic Hypermutation and Class Switching in a Human Monoclonal IgM+ IgD+ B Cell Line In Vitro: Definition of the Requirements and Modalities of Hypermutation
J. Immunol., March 15, 1999; 162(6): 3437 - 3447.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Ikematsu, J. Kobarg, H. Ikematsu, Y. Ichiyoshi, and P. Casali
Clonal Analysis of a Human Antibody Response. III. Nucleotide Sequences of Monoclonal IgM, IgG, and IgA to Rabies Virus Reveal Restricted V{kappa} Gene Utilization, Junctional V{kappa}J{kappa} and V{lambda}J{lambda} Diversity, and Somatic Hypermutation
J. Immunol., September 15, 1998; 161(6): 2895 - 2905.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. W. Bahler, J. A. Miklos, and S. H. Swerdlow
Ongoing Ig Gene Hypermutation in Salivary Gland Mucosa-Associated Lymphoid Tissue-Type Lymphomas
Blood, May 1, 1997; 89(9): 3335 - 3344.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.